Fengli Group

Fengli Group is a comprehensive Chinese pharmaceutical conglomerate that integrates research and development, manufacturing, and global distribution. The company operates primarily through its flagship subsidiary, Beijing Fengli Pharm Co., Ltd., focusing on a broad range of therapeutic areas including cardiovascular health, gastroenterology, and infectious diseases. Its portfolio comprises a diverse array of high-quality generic medications and active pharmaceutical ingredients (APIs) produced in state-of-the-art, GMP-certified facilities. Fengli Group maintains a significant international footprint, exporting products to over 50 countries and regions across Asia, Europe, and the Americas. By leveraging its integrated supply chain and strategic partnerships, the company aims to provide affordable and effective healthcare solutions on a global scale.